XBiotech Inc. (XBIT)
XBIT Stock Price Chart
Explore XBiotech Inc. interactive price chart. Choose custom timeframes to analyze XBIT price movements and trends.
XBIT Company Profile
Discover essential business fundamentals and corporate details for XBiotech Inc. (XBIT) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
15 Apr 2015
Employees
92.00
Website
https://www.xbiotech.comCEO
Sushma Shivaswamy
Description
XBiotech Inc. is a biopharmaceutical firm specializing in the discovery, development, and commercialization of True Human monoclonal antibodies. Their primary focus involves building a robust pipeline of product candidates aimed at combating both inflammatory and infectious diseases. Furthermore, the company is advancing interleukin-1 alpha-based therapies, which are designed to address a broad spectrum of medical conditions such as cancer, stroke, heart attack, and arthritis. Interleukin-1 alpha itself plays a crucial role in biological processes like tissue breakdown, angiogenesis, blood clot formation, malaise, muscle wasting, and inflammation. Additionally, XBiotech is developing a True Human COVID-19 therapy specifically targeting mutant strains of the virus. Established in 2005, XBiotech Inc. maintains its headquarters in Austin, Texas.
XBIT Financial Timeline
Browse a chronological timeline of XBiotech Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 14 May 2026
EPS came in at -$0.18 falling short of the estimated $0.03 by -700.00%.
Earnings released on 13 Mar 2026
EPS came in at -$0.88 falling short of the estimated $0.04 by -2.30k%.
Earnings released on 12 Nov 2025
EPS came in at -$0.20 .
Earnings released on 13 Aug 2025
EPS came in at -$0.06 .
Earnings released on 14 May 2025
EPS came in at -$0.36 .
Earnings released on 18 Mar 2025
EPS came in at -$0.34 .
Earnings released on 13 Nov 2024
EPS came in at -$0.16 .
Earnings released on 12 Aug 2024
EPS came in at -$0.43 .
Earnings released on 10 May 2024
EPS came in at -$0.33 .
Earnings released on 15 Mar 2024
EPS came in at -$0.16 , while revenue for the quarter reached $2.62m , missing expectations by -62.57%.
Earnings released on 9 Nov 2023
EPS came in at -$0.24 .
Earnings released on 11 Aug 2023
EPS came in at -$0.29 .
Earnings released on 10 May 2023
EPS came in at -$0.13 .
Earnings released on 15 Mar 2023
EPS came in at -$0.10 , while revenue for the quarter reached $300.00k , missing expectations by -95.71%.
Earnings released on 9 Nov 2022
EPS came in at -$0.42 , while revenue for the quarter reached $1.68m .
Earnings released on 10 Aug 2022
EPS came in at -$0.38 , while revenue for the quarter reached $1.53m , missing expectations by -78.14%.
Earnings released on 10 May 2022
EPS came in at -$0.18 , while revenue for the quarter reached $500.00k , missing expectations by -92.86%.
Earnings released on 15 Mar 2022
EPS came in at -$0.21 falling short of the estimated $0.02 by -1.15k%, while revenue for the quarter reached $4.50m , missing expectations by -35.71%.
Earnings released on 9 Nov 2021
EPS came in at -$0.11 falling short of the estimated $0.03 by -466.67%, while revenue for the quarter reached $4.52m , missing expectations by -35.44%.
Earnings released on 9 Aug 2021
EPS came in at -$0.17 falling short of the estimated $0.03 by -666.67%, while revenue for the quarter reached $4.53m , missing expectations by -35.36%.
XBIT Stock Performance
Access detailed XBIT performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
